Ondexxya - direct healthcare professional communication (DHPC)

andexanet alfa
DHPC Human

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Ondexxya
Active substance
andexanet alfa
Therapeutic area (MeSH)
Drug-Related Side Effects and Adverse Reactions
Procedure number
EMEA/H/C/004108/II/0011
Regulatory outcome
Variation
DHPC type
Adverse event
Human ATC codes
V03AB
Dissemination date

Share this page